Bio-Rad Laboratories (BIO): Q4 EPS of $2.08 may not be comparable to consensus of $1.67. Revenue...


Bio-Rad Laboratories (BIO): Q4 EPS of $2.08 may not be comparable to consensus of $1.67. Revenue of $550.2M (+3.1% Y/Y) misses by $12M. Shares -0.9% AH. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs